Therapeutic effects of ephrin B receptor 2 inhibitors screened by molecular docking on cutaneous squamous cell carcinoma
| Autor: | Xuanfen Zhang, Yan Li |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Skin Neoplasms
Cutaneous squamous cell carcinoma Dermatology Metastasis Flow cytometry 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Cell Line Tumor medicine Humans Ephrin Metastatic skin cancer Receptor Tumor xenograft Cell Proliferation Receptors Eph Family 030203 arthritis & rheumatology medicine.diagnostic_test business.industry Therapeutic effect medicine.disease Molecular Docking Simulation Carcinoma Squamous Cell Cancer research business |
| Zdroj: | Journal of Dermatological Treatment. 33:373-379 |
| ISSN: | 1471-1753 0954-6634 |
| DOI: | 10.1080/09546634.2020.1756201 |
| Popis: | Cutaneous squamous cell carcinoma (CSCC) is the most known form type of metastatic skin cancer. Activation of ephrin B receptor 2 (EphB2) signaling can promote the metastasis, invasion, and angiogenesis of CSCC cells. Therefore, EphB2 may act as a therapeutic target for CSCC. Here, we screened the inhibitors for EphB2 using molecular docking and then evaluated the effects of the identified inhibitors on cancer-related features of CSCC cells.The Schrodinger docking tool was used to predict the three-dimensional structure of EphB2 protein and its ligand binding sites, and EphB2 inhibitors were screened by high-throughput virtual screening combined with molecular docking. The effects of EphB2 inhibitors were analyzed for cell viability, proliferation, apoptosis, migration, invasion, and xenograft tumor growth.EphB2 small-molecule inhibitors had anti-CSCC effects, establishing a solid theoretical basis for clinical research. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|